The Smoking Paradox in Stroke Patients Under Reperfusion Treatment Is Associated With Endothelial Dysfunction.

endothelial dysfunction leukoaraiosis reperfusion sTWEAK stroke

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2022
Historique:
received: 22 12 2021
accepted: 22 02 2022
entrez: 11 4 2022
pubmed: 12 4 2022
medline: 12 4 2022
Statut: epublish

Résumé

This study aimed to explore the association between smoking habit and the serum levels of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK), in relation with the functional outcome of patients with acute ischemic stroke undergoing reperfusion treatment. Observational and retrospective study of a series of patients with acute ischemic stroke subjected to reperfusion treatments. Clinical, analytical, and neuroimaging parameters were analyzed. The main endpoint was the functional outcome at 3 months, measured by the modified Ranking Scale (mRS). Logistic regression models were used to analyze the association between smoking and sTWEAK levels with functional outcome and leukoaraiosis. The results showed that smoking habit was associated with a good functional outcome at 3 months in patients with stroke (OR: 3.52; 95% CI: 1.03-11.9; The decrease in sTWEAK levels was associated with a good functional outcome in smoker patients with stroke undergoing reperfusion therapy.

Identifiants

pubmed: 35401421
doi: 10.3389/fneur.2022.841484
pmc: PMC8987913
doi:

Types de publication

Journal Article

Langues

eng

Pagination

841484

Informations de copyright

Copyright © 2022 Iglesias-Rey, Custodia, Alonso-Alonso, López-Dequidt, Rodríguez-Yáñez, Pumar, Castillo, Sobrino, Campos, Silva-Candal and Hervella.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Chest. 2016 Sep;150(3):606-12
pubmed: 27108682
Neurology. 2005 Jul 26;65(2):293-5
pubmed: 16043802
PLoS One. 2017 Mar 14;12(3):e0171334
pubmed: 28291782
Medicine (Baltimore). 2019 Mar;98(12):e14872
pubmed: 30896633
Stroke. 2020 Apr;51(4):1248-1256
pubmed: 32151234
Stroke. 2013 Feb;44(2):407-13
pubmed: 23287785
Cell Physiol Biochem. 2018;48(4):1638-1651
pubmed: 30077999
J Exp Med. 2011 Mar 14;208(3):429-37
pubmed: 21357744
Stroke. 2011 Aug;42(8):2330-2
pubmed: 21757671
Fluids Barriers CNS. 2015 Oct 31;12:25
pubmed: 26520792
Front Immunol. 2017 Nov 16;8:1534
pubmed: 29201025
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
Int Heart J. 2017 Aug 3;58(4):506-515
pubmed: 28701668
Brain Res. 2009 Sep 1;1287:192-205
pubmed: 19539613
Front Neurol. 2021 May 11;12:652867
pubmed: 34046003
Life Sci. 2012 Nov 27;91(21-22):1058-64
pubmed: 22796717
Front Neurol. 2019 Nov 22;10:1239
pubmed: 31824412
Pharmacol Res. 2017 Jul;121:240-250
pubmed: 28506796
J Am Coll Cardiol. 2017 Jul 11;70(2):230-251
pubmed: 28683970
QJM. 1999 Jun;92(6):327-33
pubmed: 10616708
Int J Epidemiol. 2015 Jun;44(3):735-43
pubmed: 26174518
AJR Am J Roentgenol. 1987 Aug;149(2):351-6
pubmed: 3496763
J Pharmacol Exp Ther. 2006 Jan;316(1):248-54
pubmed: 16174793
Nicotine Tob Res. 2017 Jul 01;19(7):871-876
pubmed: 28339617
Biol Pharm Bull. 2018;41(9):1330-1336
pubmed: 30175770
Nat Rev Drug Discov. 2008 May;7(5):411-25
pubmed: 18404150
Front Immunol. 2018 Jan 25;9:67
pubmed: 29422904
Ann Transl Med. 2019 Sep;7(18):489
pubmed: 31700925
Front Immunol. 2014 Jan 20;5:3
pubmed: 24478772
Regul Toxicol Pharmacol. 2018 Nov;99:122-128
pubmed: 30227175
Tob Induc Dis. 2019 Oct 07;17:72
pubmed: 31768164
Circulation. 1975 Jun;51(6):1120-3
pubmed: 1132101
Stroke. 1999 Mar;30(3):651-5
pubmed: 10066866
J Neurochem. 2018 Mar;144(5):617-633
pubmed: 29210074
J Pharmacol Exp Ther. 2019 Feb;368(2):169-178
pubmed: 30446578
BMC Med. 2019 Jul 3;17(1):128
pubmed: 31266500
J Am Heart Assoc. 2013 Jun 19;2(3):e000171
pubmed: 23782919
Front Neurosci. 2020 May 21;14:513
pubmed: 32670001
Womens Health (Lond). 2011 May;7(3):383-90
pubmed: 21612358
Transl Stroke Res. 2019 Dec;10(6):639-649
pubmed: 30980283
Nicotine Tob Res. 2019 Aug 19;21(9):1181-1188
pubmed: 31219582
Stroke. 2008 Dec;39(12):3316-22
pubmed: 18927461
F1000Res. 2018 Feb 19;7:204
pubmed: 30800285
Stroke. 2001 Jun;32(6):1330-5
pubmed: 11387495

Auteurs

Ramón Iglesias-Rey (R)

Neuroimaging and Biotechnology Laboratory, Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain.
Clinical Neurosciences Research Laboratories, Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain.

Antía Custodia (A)

Clinical Neurosciences Research Laboratories, Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain.
NeuroAging Group, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.

Maria Luz Alonso-Alonso (ML)

Neuroimaging and Biotechnology Laboratory, Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain.
Clinical Neurosciences Research Laboratories, Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain.

Iria López-Dequidt (I)

Stroke Unit, Department of Neurology, Hospital Clínico Universitario, Santiago de Compostela, Santiago de Compostela, Spain.

Manuel Rodríguez-Yáñez (M)

Stroke Unit, Department of Neurology, Hospital Clínico Universitario, Santiago de Compostela, Santiago de Compostela, Spain.

José M Pumar (JM)

Neuroimaging and Biotechnology Laboratory, Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain.
Department of Neuroradiology, Hospital Clínico Universitario de Santiago de Compostela, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.

José Castillo (J)

Neuroimaging and Biotechnology Laboratory, Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain.
Clinical Neurosciences Research Laboratories, Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain.

Tomás Sobrino (T)

Clinical Neurosciences Research Laboratories, Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain.
NeuroAging Group, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.

Francisco Campos (F)

Clinical Neurosciences Research Laboratories, Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain.

Andres da Silva-Candal (A)

Clinical Neurosciences Research Laboratories, Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain.
Neurovascular Diseases Laboratory, Neurology Service, University Hospital Complex of A Coruña, Biomedical Research Institute, A Coruña, Spain.

Pablo Hervella (P)

Neuroimaging and Biotechnology Laboratory, Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain.
Clinical Neurosciences Research Laboratories, Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain.

Classifications MeSH